Barbara Finck
Impact in
- Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Biosimilars and Bioanalytical Methods 6
- T-cell and B-cell Immunology 3
- Oncology 8
- Neutropenia and Cancer Infections 4
- Co-authors
- Daniel Burge (2 shared papers)Philip J. Mease (1 shared paper)Bernard S. Goffe (1 shared paper)James M. Metz (1 shared paper)Ann VanderStoep (1 shared paper)Michael Schiff (2 shared papers)Arthur L. Weaver (2 shared papers)Larry W. Moreland (2 shared papers)
- Journals
- Advances in Therapy (4 papers)Annals of the Rheumatic Diseases (3 papers)Journal of Clinical Oncology (2 papers)Neurology (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Barbara Finck
17 papers receiving 3.4k citations
Barbara Finck's Hit Papers
Peers
Comparison fields: 5 of 93
- Rheumatology 2.5k
- Hematology 996
- Immunology 1.1k
- Genetics 206
- Dermatology 137
Countries citing papers authored by Barbara Finck
This map shows the geographic impact of Barbara Finck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Finck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Finck more than expected).
Fields of papers citing papers by Barbara Finck
This network shows the impact of papers produced by Barbara Finck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Finck. The network helps show where Barbara Finck may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Finck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Hit paper breakdown → | 2000 | 1404 |
| 2 | Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial Hit paper breakdown → | 2000 | 1114 |
| 3 | Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes Hit paper breakdown → | 2002 | 573 |
| 4 | 1994 | 201 | |
| 5 | 2003 | 182 | |
| 6 | 1998 | 44 | |
| 7 | 2020 | 14 | |
| 8 | 2016 | 12 | |
| 9 | 2017 | 7 | |
| 10 | 2017 | 6 | |
| 11 | 1992 | 6 | |
| 12 | 2023 | 3 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2022 | 1 |
About Barbara Finck
Barbara Finck is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 3.6k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Neutropenia and Cancer Infections (4 papers), T-cell and B-cell Immunology (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Blood disorders and treatments (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Rheumatology (2.5k citations), Hematology (996 citations), Immunology (1.1k citations), Genetics (206 citations) and Dermatology (137 citations). Barbara Finck has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Daniel Burge, Philip J. Mease, Bernard S. Goffe, James M. Metz, Ann VanderStoep, Michael Schiff, Arthur L. Weaver, Larry W. Moreland, Edward Keystone and Roy Fleischmann. Their work appears in journals such as Advances in Therapy, Annals of the Rheumatic Diseases, Journal of Clinical Oncology, Neurology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.